Blue Owl Capital Holdings’s NKGen Biotech, Inc. Warrants NKGNW Stock Holding History

Blue Owl Capital Holdings’s Portfolio NKGNW Stock Details NKGNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-30,000	Closed	-$3K	–	81
2024 Q4	$3K	Hold	30,000	–	–	﹤0.01%	72
2024 Q3	$2.1K	Buy	+30,000	New	+$2.68K	﹤0.01%	104

Other funds holding NKGNW

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.79% 1-Year Est. Return

MTCM

Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 18.84% 1-Year Est. Return

Blue Owl Capital Holdings's NKGNW Position: Q1 2025 in Review

Blue Owl Capital Holdings sold out of NKGen Biotech, Inc. Warrants (NKGNW) in Q1 2025, closing a stake of 30,000 shares — an estimated $3K sold.

Blue Owl Capital Holdings first reported a position in NKGNW in Q3 2024 and held it in 2 quarters. The position peaked at $3K in Q4 2024. 3 funds tracked by Wall St. Rank hold NKGNW as of Q1 2025.

Blue Owl Capital Holdings reported no remaining NKGen Biotech, Inc. Warrants position as of Q1 2025 after selling out during the quarter.
Blue Owl Capital Holdings sold 30,000 NKGen Biotech, Inc. Warrants shares in Q1 2025, an estimated $3K.
Blue Owl Capital Holdings first reported a position in NKGen Biotech, Inc. Warrants in Q3 2024 and held it in 2 quarters.
Blue Owl Capital Holdings's NKGen Biotech, Inc. Warrants position peaked at $3K in Q4 2024.
3 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Warrants as of Q1 2025.

Based on Blue Owl Capital Holdings's 13F filing for Q1 2025, filed 15 May 2025.